Characterization of circulating tumor cells as a reflection of the tumor heterogeneity: myth or reality?
•Circulating tumor cells are highly heterogeneous in a spatial and temporal manner.•Circulating-tumor cells are a reflection of the tumor tissue at a fixed time.•Circulating-tumor cells exhibit a dynamic phenotype and genomic profile.•Circulating-tumor cells are the photograph of tumor evolution.•Ge...
Gespeichert in:
Veröffentlicht in: | Drug discovery today 2019-03, Vol.24 (3), p.763-772 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 772 |
---|---|
container_issue | 3 |
container_start_page | 763 |
container_title | Drug discovery today |
container_volume | 24 |
creator | Brown, Hannah K. Tellez-Gabriel, Marta Cartron, Pierre-François Vallette, François M. Heymann, Marie-Francoise Heymann, Dominique |
description | •Circulating tumor cells are highly heterogeneous in a spatial and temporal manner.•Circulating-tumor cells are a reflection of the tumor tissue at a fixed time.•Circulating-tumor cells exhibit a dynamic phenotype and genomic profile.•Circulating-tumor cells are the photograph of tumor evolution.•Genomic and downstream RNA analyses of CTCs are promising to monitor the therapeutic response.
The current main goal of diagnostic medicine is to detect crucial events in ‘infinitely’ small samples. The key question now is how to determine whether the rare cell events isolated and characterized from these samples reliably reflect the disease and heterogeneity of the tumor. In this review, we provide a short overview of the most recent methods developed for the isolation and characterization of rare cell events in clinical practice, with a specific focus on circulating tumor cells. We discuss the biological value to studying these cells at the single cell level and how these rare cell events can reflect tumor heterogeneity. The potential biomedical applications are also critically discussed in light of precision medicine. |
doi_str_mv | 10.1016/j.drudis.2018.11.017 |
format | Article |
fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_proquest_miscellaneous_2141046458</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1359644618301624</els_id><sourcerecordid>2141046458</sourcerecordid><originalsourceid>FETCH-LOGICAL-c445t-5a489fce08f3b5063b8201b92387185f28bc8cdabb44cb4273afcf1a6a697a7e3</originalsourceid><addsrcrecordid>eNp9kUFr3DAQhUVoSdJN_kEoPvZQuxpLluQcUsLSNoWFXpqzkOVxrMW2UskObH99tXiTY0EgafjmDfMeITdAC6AgvuyLNiyti0VJQRUABQV5Ri5BSZVXipXv0ptVdS44FxfkQ4x7SqGsK3FOLhjltVAVuyT9tjfB2BmD-2tm56fMd5l1wS5D-k5P2byMPmQWhyFmJp0sYDegfUXnHk9Ij0nEP-GEbj7cZuNh7rNUDmiGVPh6Rd53Zoh4fbo35PH7t9_bh3z368fP7f0ut5xXc14ZrurOIlUdayoqWKPSfk1dMiVBVV2pGqtsa5qGc9vwUjLT2Q6MMKKWRiLbkM-rbm8G_RzcaMJBe-P0w_1OuyliGDWFmksuyxdI-KcVfw7-z4Jx1qOLx23NhH6JugQOlAueHN0QvqI2-BiTDW_yQPUxEr3XayT6GIkGSINkavt4mrA0I7ZvTa8ZJOBuBTDZ8uIw6GgdThZbF5LRuvXu_xP-AbvCoCk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2141046458</pqid></control><display><type>article</type><title>Characterization of circulating tumor cells as a reflection of the tumor heterogeneity: myth or reality?</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Brown, Hannah K. ; Tellez-Gabriel, Marta ; Cartron, Pierre-François ; Vallette, François M. ; Heymann, Marie-Francoise ; Heymann, Dominique</creator><creatorcontrib>Brown, Hannah K. ; Tellez-Gabriel, Marta ; Cartron, Pierre-François ; Vallette, François M. ; Heymann, Marie-Francoise ; Heymann, Dominique</creatorcontrib><description>•Circulating tumor cells are highly heterogeneous in a spatial and temporal manner.•Circulating-tumor cells are a reflection of the tumor tissue at a fixed time.•Circulating-tumor cells exhibit a dynamic phenotype and genomic profile.•Circulating-tumor cells are the photograph of tumor evolution.•Genomic and downstream RNA analyses of CTCs are promising to monitor the therapeutic response.
The current main goal of diagnostic medicine is to detect crucial events in ‘infinitely’ small samples. The key question now is how to determine whether the rare cell events isolated and characterized from these samples reliably reflect the disease and heterogeneity of the tumor. In this review, we provide a short overview of the most recent methods developed for the isolation and characterization of rare cell events in clinical practice, with a specific focus on circulating tumor cells. We discuss the biological value to studying these cells at the single cell level and how these rare cell events can reflect tumor heterogeneity. The potential biomedical applications are also critically discussed in light of precision medicine.</description><identifier>ISSN: 1359-6446</identifier><identifier>ISSN: 1741-8364</identifier><identifier>EISSN: 1878-5832</identifier><identifier>DOI: 10.1016/j.drudis.2018.11.017</identifier><identifier>PMID: 30496853</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Animals ; Cancer ; Endocrinology and metabolism ; Human health and pathology ; Humans ; Life Sciences ; Neoplasms - genetics ; Neoplastic Cells, Circulating ; Pediatrics ; Rhumatology and musculoskeletal system</subject><ispartof>Drug discovery today, 2019-03, Vol.24 (3), p.763-772</ispartof><rights>2018</rights><rights>Crown Copyright © 2018. Published by Elsevier Ltd. All rights reserved.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c445t-5a489fce08f3b5063b8201b92387185f28bc8cdabb44cb4273afcf1a6a697a7e3</citedby><cites>FETCH-LOGICAL-c445t-5a489fce08f3b5063b8201b92387185f28bc8cdabb44cb4273afcf1a6a697a7e3</cites><orcidid>0000-0001-7777-0669 ; 0000-0002-0895-2677 ; 0000-0002-3393-784X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.drudis.2018.11.017$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30496853$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://inserm.hal.science/inserm-01947472$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Brown, Hannah K.</creatorcontrib><creatorcontrib>Tellez-Gabriel, Marta</creatorcontrib><creatorcontrib>Cartron, Pierre-François</creatorcontrib><creatorcontrib>Vallette, François M.</creatorcontrib><creatorcontrib>Heymann, Marie-Francoise</creatorcontrib><creatorcontrib>Heymann, Dominique</creatorcontrib><title>Characterization of circulating tumor cells as a reflection of the tumor heterogeneity: myth or reality?</title><title>Drug discovery today</title><addtitle>Drug Discov Today</addtitle><description>•Circulating tumor cells are highly heterogeneous in a spatial and temporal manner.•Circulating-tumor cells are a reflection of the tumor tissue at a fixed time.•Circulating-tumor cells exhibit a dynamic phenotype and genomic profile.•Circulating-tumor cells are the photograph of tumor evolution.•Genomic and downstream RNA analyses of CTCs are promising to monitor the therapeutic response.
The current main goal of diagnostic medicine is to detect crucial events in ‘infinitely’ small samples. The key question now is how to determine whether the rare cell events isolated and characterized from these samples reliably reflect the disease and heterogeneity of the tumor. In this review, we provide a short overview of the most recent methods developed for the isolation and characterization of rare cell events in clinical practice, with a specific focus on circulating tumor cells. We discuss the biological value to studying these cells at the single cell level and how these rare cell events can reflect tumor heterogeneity. The potential biomedical applications are also critically discussed in light of precision medicine.</description><subject>Animals</subject><subject>Cancer</subject><subject>Endocrinology and metabolism</subject><subject>Human health and pathology</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Neoplasms - genetics</subject><subject>Neoplastic Cells, Circulating</subject><subject>Pediatrics</subject><subject>Rhumatology and musculoskeletal system</subject><issn>1359-6446</issn><issn>1741-8364</issn><issn>1878-5832</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUFr3DAQhUVoSdJN_kEoPvZQuxpLluQcUsLSNoWFXpqzkOVxrMW2UskObH99tXiTY0EgafjmDfMeITdAC6AgvuyLNiyti0VJQRUABQV5Ri5BSZVXipXv0ptVdS44FxfkQ4x7SqGsK3FOLhjltVAVuyT9tjfB2BmD-2tm56fMd5l1wS5D-k5P2byMPmQWhyFmJp0sYDegfUXnHk9Ij0nEP-GEbj7cZuNh7rNUDmiGVPh6Rd53Zoh4fbo35PH7t9_bh3z368fP7f0ut5xXc14ZrurOIlUdayoqWKPSfk1dMiVBVV2pGqtsa5qGc9vwUjLT2Q6MMKKWRiLbkM-rbm8G_RzcaMJBe-P0w_1OuyliGDWFmksuyxdI-KcVfw7-z4Jx1qOLx23NhH6JugQOlAueHN0QvqI2-BiTDW_yQPUxEr3XayT6GIkGSINkavt4mrA0I7ZvTa8ZJOBuBTDZ8uIw6GgdThZbF5LRuvXu_xP-AbvCoCk</recordid><startdate>20190301</startdate><enddate>20190301</enddate><creator>Brown, Hannah K.</creator><creator>Tellez-Gabriel, Marta</creator><creator>Cartron, Pierre-François</creator><creator>Vallette, François M.</creator><creator>Heymann, Marie-Francoise</creator><creator>Heymann, Dominique</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0001-7777-0669</orcidid><orcidid>https://orcid.org/0000-0002-0895-2677</orcidid><orcidid>https://orcid.org/0000-0002-3393-784X</orcidid></search><sort><creationdate>20190301</creationdate><title>Characterization of circulating tumor cells as a reflection of the tumor heterogeneity: myth or reality?</title><author>Brown, Hannah K. ; Tellez-Gabriel, Marta ; Cartron, Pierre-François ; Vallette, François M. ; Heymann, Marie-Francoise ; Heymann, Dominique</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c445t-5a489fce08f3b5063b8201b92387185f28bc8cdabb44cb4273afcf1a6a697a7e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>Cancer</topic><topic>Endocrinology and metabolism</topic><topic>Human health and pathology</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Neoplasms - genetics</topic><topic>Neoplastic Cells, Circulating</topic><topic>Pediatrics</topic><topic>Rhumatology and musculoskeletal system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brown, Hannah K.</creatorcontrib><creatorcontrib>Tellez-Gabriel, Marta</creatorcontrib><creatorcontrib>Cartron, Pierre-François</creatorcontrib><creatorcontrib>Vallette, François M.</creatorcontrib><creatorcontrib>Heymann, Marie-Francoise</creatorcontrib><creatorcontrib>Heymann, Dominique</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>Drug discovery today</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brown, Hannah K.</au><au>Tellez-Gabriel, Marta</au><au>Cartron, Pierre-François</au><au>Vallette, François M.</au><au>Heymann, Marie-Francoise</au><au>Heymann, Dominique</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterization of circulating tumor cells as a reflection of the tumor heterogeneity: myth or reality?</atitle><jtitle>Drug discovery today</jtitle><addtitle>Drug Discov Today</addtitle><date>2019-03-01</date><risdate>2019</risdate><volume>24</volume><issue>3</issue><spage>763</spage><epage>772</epage><pages>763-772</pages><issn>1359-6446</issn><issn>1741-8364</issn><eissn>1878-5832</eissn><abstract>•Circulating tumor cells are highly heterogeneous in a spatial and temporal manner.•Circulating-tumor cells are a reflection of the tumor tissue at a fixed time.•Circulating-tumor cells exhibit a dynamic phenotype and genomic profile.•Circulating-tumor cells are the photograph of tumor evolution.•Genomic and downstream RNA analyses of CTCs are promising to monitor the therapeutic response.
The current main goal of diagnostic medicine is to detect crucial events in ‘infinitely’ small samples. The key question now is how to determine whether the rare cell events isolated and characterized from these samples reliably reflect the disease and heterogeneity of the tumor. In this review, we provide a short overview of the most recent methods developed for the isolation and characterization of rare cell events in clinical practice, with a specific focus on circulating tumor cells. We discuss the biological value to studying these cells at the single cell level and how these rare cell events can reflect tumor heterogeneity. The potential biomedical applications are also critically discussed in light of precision medicine.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>30496853</pmid><doi>10.1016/j.drudis.2018.11.017</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-7777-0669</orcidid><orcidid>https://orcid.org/0000-0002-0895-2677</orcidid><orcidid>https://orcid.org/0000-0002-3393-784X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1359-6446 |
ispartof | Drug discovery today, 2019-03, Vol.24 (3), p.763-772 |
issn | 1359-6446 1741-8364 1878-5832 |
language | eng |
recordid | cdi_proquest_miscellaneous_2141046458 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Animals Cancer Endocrinology and metabolism Human health and pathology Humans Life Sciences Neoplasms - genetics Neoplastic Cells, Circulating Pediatrics Rhumatology and musculoskeletal system |
title | Characterization of circulating tumor cells as a reflection of the tumor heterogeneity: myth or reality? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T19%3A55%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterization%20of%20circulating%20tumor%20cells%20as%20a%20reflection%20of%20the%20tumor%20heterogeneity:%20myth%20or%20reality?&rft.jtitle=Drug%20discovery%20today&rft.au=Brown,%20Hannah%20K.&rft.date=2019-03-01&rft.volume=24&rft.issue=3&rft.spage=763&rft.epage=772&rft.pages=763-772&rft.issn=1359-6446&rft.eissn=1878-5832&rft_id=info:doi/10.1016/j.drudis.2018.11.017&rft_dat=%3Cproquest_hal_p%3E2141046458%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2141046458&rft_id=info:pmid/30496853&rft_els_id=S1359644618301624&rfr_iscdi=true |